Skip to Content

IG 279 (Topiramate 50 mg)

Pill with imprint IG 279 is Yellow, Round and has been identified as Topiramate 50 mg. It is supplied by InvaGen Pharmaceuticals, Inc..

Topiramate is used in the treatment of epilepsy; lennox-gastaut syndrome; seizure prevention; migraine prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for IG 279

Topiramate 50 mg IG 279
Topiramate 50 mg IG 279 Front
Topiramate 50 mg IG 279 Back
Topiramate 50 mg IG 279
Topiramate 50 mg IG 279
Topiramate 50 mg IG 279

Topiramate

Imprint
IG 279
Strength
50 mg
Color
Yellow
Size
7.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
InvaGen Pharmaceuticals, Inc.
Inactive Ingredients
lactose monohydrate, microcrystalline cellulose, corn starch, sodium starch glycolate type A potato, magnesium stearate, silicon dioxide, hypromellose 2910 (3 mPa.s), hypromellose 2910 (6 mPa.s), polyethylene glycol 400, polysorbate 80, ferric oxide yellow

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
31722-0279 Camber Pharmaceuticals, Inc.
60429-0770 Golden State Medical Supply (repackager)
33261-0400 Aidarex Pharmacuticals, LLC (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.